{"id":"W1125943938","doi":"10.1212/wnl.84.14_supplement.p7.230","title":"Safety and Tolerability Results From the DECIDE Study: A Phase 3 Active-Comparator Study of Daclizumab HYP in Relapsing-Remitting Multiple Sclerosis (P7.230)","year":2015,"lang":"en","type":"article","venue":"Neurology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"","keywords":"Tolerability; Relapsing remitting; Multiple sclerosis; Daclizumab; Medicine; Internal medicine; Adverse effect; Psychiatry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00261831,0.001125015,0.002333958,0.0003395225,0.0003997386,0.0008136491,0.0008403222,0.001135352,0.004089392],"category_scores_gemma":[0.002708898,0.0005261956,0.00126902,0.0004089883,0.0009528429,0.000768935,0.000407523,0.001850144,0.0005125052],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005348417,"about_ca_system_score_gemma":0.0009433869,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004743358,"about_ca_topic_score_gemma":0.001372359,"domain_scores_codex":[0.9987479,0.0007613199,0.00007191529,0.0001395392,0.0002003049,0.00007896504],"domain_scores_gemma":[0.9979153,0.0006099705,0.0006715078,0.0001486784,0.0001538342,0.0005006983],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9451833,0.01323481,0.003744991,0.0006615533,0.001590695,0.0001571777,0.00008973417,0.0007265447,0.01386111,0.000101338,0.001092568,0.01955606],"study_design_scores_gemma":[0.7841809,0.1979524,0.01233039,0.00003032498,0.001011955,0.0002234324,0.00003876338,0.0005785631,0.002183242,0.00008772212,0.001354489,0.00002773247],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928758,0.002046719,0.0004529127,0.0001688518,0.00006857342,0.001663503,0.001351841,0.00005245806,0.001319405],"genre_scores_gemma":[0.9927753,0.001117157,0.001285259,0.0004279299,0.0001837868,0.001581823,0.001824792,0.00002108542,0.0007828276],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004089392,"threshold_uncertainty_score":0.01384711,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06349894647787813,"score_gpt":0.2898387338951635,"score_spread":0.2263397874172853,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}